Loading insider details...
Beta
Latest Form 4 (Sep 18, 2024): Exercise/Conversion of 12,562 ELEV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2024 | Elevation Oncology, Inc. (ELEV) | Exercise/Conversion | 12,562 | n/a |
| Jun 18, 2024 | Elevation Oncology, Inc. (ELEV) | Exercise/Conversion | 12,562 | n/a |
| Mar 19, 2024 | Elevation Oncology, Inc. (ELEV) | Exercise/Conversion | 12,562 | n/a |
| Feb 20, 2024 | Elevation Oncology, Inc. (ELEV) | Grant/Award | 600,000 | n/a |
| Feb 19, 2021 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 119,000 | n/a |
| Feb 14, 2020 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 94,000 | n/a |